Global BCG Vaccine Market Insights and Forecast to 2026 by Top Companies
出 版 商：XYZ Research
出版日期：2019/12/01
頁 數：103頁
文件格式：PDF
價 格：
USD 3,150 (Single-User License)
USD 6,200 (Global-User License)
USD 6,200 (Global-User License)
In this report,global BCG Vaccine Market will reach 342.56 Million USD by the end of 2022 with a CAGR of 4.54%
The global BCG Vaccine market is valued at 274.34 Million USD in 2017 and will reach 342.56 Million USD by the end of 2022, growing at a CAGR of 4.54% during 2017-2022.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guerin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
BCG Vaccine can be divided into two categories—Immune BCG and Therapy BCG type. Therapy BCG type production market share accounted for the highest proportion, with a figure of 94.81% in 2017, Immune BCG type account for 5.19%.
The consumption market share of global BCG Vaccine in Hospital use and Clinic use have been stable year by year, at 74.20% and 25.80% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the BCG Vaccine in the global market tends to be fixed without great changes. Among them, the BCG Vaccine market has the most promising sales prospects in Hospital use.
XYZ research center data shows that North America is the biggest contributor to the BCG Vaccine revenue market, accounted for 34.75% of the total global market with a revenue of 95.32 million USD in 2017, followed by Europe, 32.34% with a revenue of 88.72 million USD.
Market competition is not intense. Sanofi Pasteur is the largest company in the global BCG Vaccine market, accounted for 33.61% of the revenue market share in 2017, followed by Merck and Japan BCG Lab, accounted for 32.71% and 18.34% of the revenue market share in 2017.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of BCG Vaccine in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global BCG Vaccine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Others
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Immune BCG
Therapy BCG
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of BCG Vaccine for each application, including
Hospitals
Clinics
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
The global BCG Vaccine market is valued at 274.34 Million USD in 2017 and will reach 342.56 Million USD by the end of 2022, growing at a CAGR of 4.54% during 2017-2022.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guerin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
BCG Vaccine can be divided into two categories—Immune BCG and Therapy BCG type. Therapy BCG type production market share accounted for the highest proportion, with a figure of 94.81% in 2017, Immune BCG type account for 5.19%.
The consumption market share of global BCG Vaccine in Hospital use and Clinic use have been stable year by year, at 74.20% and 25.80% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the BCG Vaccine in the global market tends to be fixed without great changes. Among them, the BCG Vaccine market has the most promising sales prospects in Hospital use.
XYZ research center data shows that North America is the biggest contributor to the BCG Vaccine revenue market, accounted for 34.75% of the total global market with a revenue of 95.32 million USD in 2017, followed by Europe, 32.34% with a revenue of 88.72 million USD.
Market competition is not intense. Sanofi Pasteur is the largest company in the global BCG Vaccine market, accounted for 33.61% of the revenue market share in 2017, followed by Merck and Japan BCG Lab, accounted for 32.71% and 18.34% of the revenue market share in 2017.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of BCG Vaccine in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global BCG Vaccine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Others
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Immune BCG
Therapy BCG
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of BCG Vaccine for each application, including
Hospitals
Clinics
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global BCG Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 BCG Vaccine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Immune BCG Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Therapy BCG Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific BCG Vaccine Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America BCG Vaccine Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe BCG Vaccine Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America BCG Vaccine Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa BCG Vaccine Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World BCG Vaccine Market Assessment by Type
8.1 Asia Pacific BCG Vaccine Market Assessment by Application (Consumption and Market Share)
8.2 North America BCG Vaccine Market Assessment by Application (Consumption and Market Share)
8.3 Europe BCG Vaccine Market Assessment by Application (Consumption and Market Share)
8.4 South America BCG Vaccine Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa BCG Vaccine Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Merck
9.1.1 Merck Profiles
9.1.2 Merck Product Portfolio
9.1.3 Merck BCG Vaccine Business Performance
9.1.4 Merck BCG Vaccine Business Development and Market Status
9.2 Sanofi Pasteur
9.2.1 Sanofi Pasteur Profiles
9.2.2 Sanofi Pasteur Product Portfolio
9.2.3 Sanofi Pasteur BCG Vaccine Business Performance
9.2.4 Sanofi Pasteur BCG Vaccine Business Development and Market Status
9.3 Japan BCG Lab
9.3.1 Japan BCG Lab Profiles
9.3.2 Japan BCG Lab Product Portfolio
9.3.3 Japan BCG Lab BCG Vaccine Business Performance
9.3.4 Japan BCG Lab BCG Vaccine Business Development and Market Status
9.4 China National Biotec
9.4.1 China National Biotec Profiles
9.4.2 China National Biotec Product Portfolio
9.4.3 China National Biotec BCG Vaccine Business Performance
9.4.4 China National Biotec BCG Vaccine Business Development and Market Status
9.5 Serum Institute of India
9.5.1 Serum Institute of India Profiles
9.5.2 Serum Institute of India Product Portfolio
9.5.3 Serum Institute of India BCG Vaccine Business Performance
9.5.4 Serum Institute of India BCG Vaccine Business Development and Market Status
9.6 Intervax
9.6.1 Intervax Profiles
9.6.2 Intervax Product Portfolio
9.6.3 Intervax BCG Vaccine Business Performance
9.6.4 Intervax BCG Vaccine Business Development and Market Status
9.7 GSBPL
9.7.1 GSBPL Profiles
9.7.2 GSBPL Product Portfolio
9.7.3 GSBPL BCG Vaccine Business Performance
9.7.4 GSBPL BCG Vaccine Business Development and Market Status
9.8 Others
9.8.1 Others Profiles
9.8.2 Others Product Portfolio
9.8.3 Others BCG Vaccine Business Performance
9.8.4 Others BCG Vaccine Business Development and Market Status
10 World BCG Vaccine Market Assessment by Players
10.1 Global BCG Vaccine Sales (K Units) and Market Share by Players 2014-2020
10.2 Global BCG Vaccine Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global BCG Vaccine Price (USD/Unit) of Players 2014-2020
10.4 Global BCG Vaccine Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America BCG Vaccine Sales Assessment of Players 2014-2020
11.1.2 North America BCG Vaccine Revenue Assessment of Players 2014-2020
11.1.3 North America BCG Vaccine Price Assessment of Players 2014-2020
11.1.4 North America BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe BCG Vaccine Sales Assessment of Players 2014-2020
11.2.2 Europe BCG Vaccine Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe BCG Vaccine Price Assessment of Players 2014-2020
11.2.4 Europe BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific BCG Vaccine Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific BCG Vaccine Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific BCG Vaccine Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America BCG Vaccine Sales Assessment of Players 2014-2020
11.4.2 South America BCG Vaccine Revenue Assessment of Players 2014-2020
11.4.3 South America BCG Vaccine Price Assessment of Players 2014-2020
11.4.4 South America BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa BCG Vaccine Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa BCG Vaccine Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa BCG Vaccine Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific BCG Vaccine Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific BCG Vaccine Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific BCG Vaccine Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America BCG Vaccine Sales by Countries/Regions 2014-2020
12.2.2 North America BCG Vaccine Revenue by Countries/Regions 2014-2020
12.2.3 North America BCG Vaccine Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe BCG Vaccine Sales by Countries/Regions 2014-2020
12.3.2 Europe BCG Vaccine Revenue by Countries/Regions 2014-2020
12.3.3 Europe BCG Vaccine Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America BCG Vaccine Sales by Countries/Regions 2014-2020
12.4.2 South America BCG Vaccine Revenue by Countries/Regions 2014-2020
12.4.3 South America BCG Vaccine Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa BCG Vaccine Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa BCG Vaccine Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa BCG Vaccine Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World BCG Vaccine Sales & Revenue Forecast 2021-2026
14.1 World BCG Vaccine Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World BCG VaccineSales and Market Share by Regions
14.1.2 World BCG VaccineRevenue and Market Share by Regions
15 Asia BCG Vaccine Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Immune BCG
15.1.2 Therapy BCG
15.2 Consumption Forecast by Application, 2021-2026
16 North America BCG Vaccine Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Immune BCG
16.1.2 Therapy BCG
16.2 Consumption Forecast by Application, 2021-2026
17 Europe BCG Vaccine Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Immune BCG
17.1.2 Therapy BCG
17.2 Consumption Forecast by Application, 2021-2026
18 South America BCG Vaccine Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Immune BCG
18.1.2 Therapy BCG
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa BCG Vaccine Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Immune BCG
19.1.2 Therapy BCG
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global BCG Vaccine Price (USD/Unit) Trend 2021-2026
20.2 Global BCG Vaccine Gross Profit Trend 2021-2026
21 Conclusion
Global BCG Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 BCG Vaccine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Immune BCG Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Therapy BCG Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific BCG Vaccine Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America BCG Vaccine Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe BCG Vaccine Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America BCG Vaccine Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa BCG Vaccine Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World BCG Vaccine Market Assessment by Type
8.1 Asia Pacific BCG Vaccine Market Assessment by Application (Consumption and Market Share)
8.2 North America BCG Vaccine Market Assessment by Application (Consumption and Market Share)
8.3 Europe BCG Vaccine Market Assessment by Application (Consumption and Market Share)
8.4 South America BCG Vaccine Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa BCG Vaccine Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Merck
9.1.1 Merck Profiles
9.1.2 Merck Product Portfolio
9.1.3 Merck BCG Vaccine Business Performance
9.1.4 Merck BCG Vaccine Business Development and Market Status
9.2 Sanofi Pasteur
9.2.1 Sanofi Pasteur Profiles
9.2.2 Sanofi Pasteur Product Portfolio
9.2.3 Sanofi Pasteur BCG Vaccine Business Performance
9.2.4 Sanofi Pasteur BCG Vaccine Business Development and Market Status
9.3 Japan BCG Lab
9.3.1 Japan BCG Lab Profiles
9.3.2 Japan BCG Lab Product Portfolio
9.3.3 Japan BCG Lab BCG Vaccine Business Performance
9.3.4 Japan BCG Lab BCG Vaccine Business Development and Market Status
9.4 China National Biotec
9.4.1 China National Biotec Profiles
9.4.2 China National Biotec Product Portfolio
9.4.3 China National Biotec BCG Vaccine Business Performance
9.4.4 China National Biotec BCG Vaccine Business Development and Market Status
9.5 Serum Institute of India
9.5.1 Serum Institute of India Profiles
9.5.2 Serum Institute of India Product Portfolio
9.5.3 Serum Institute of India BCG Vaccine Business Performance
9.5.4 Serum Institute of India BCG Vaccine Business Development and Market Status
9.6 Intervax
9.6.1 Intervax Profiles
9.6.2 Intervax Product Portfolio
9.6.3 Intervax BCG Vaccine Business Performance
9.6.4 Intervax BCG Vaccine Business Development and Market Status
9.7 GSBPL
9.7.1 GSBPL Profiles
9.7.2 GSBPL Product Portfolio
9.7.3 GSBPL BCG Vaccine Business Performance
9.7.4 GSBPL BCG Vaccine Business Development and Market Status
9.8 Others
9.8.1 Others Profiles
9.8.2 Others Product Portfolio
9.8.3 Others BCG Vaccine Business Performance
9.8.4 Others BCG Vaccine Business Development and Market Status
10 World BCG Vaccine Market Assessment by Players
10.1 Global BCG Vaccine Sales (K Units) and Market Share by Players 2014-2020
10.2 Global BCG Vaccine Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global BCG Vaccine Price (USD/Unit) of Players 2014-2020
10.4 Global BCG Vaccine Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America BCG Vaccine Sales Assessment of Players 2014-2020
11.1.2 North America BCG Vaccine Revenue Assessment of Players 2014-2020
11.1.3 North America BCG Vaccine Price Assessment of Players 2014-2020
11.1.4 North America BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe BCG Vaccine Sales Assessment of Players 2014-2020
11.2.2 Europe BCG Vaccine Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe BCG Vaccine Price Assessment of Players 2014-2020
11.2.4 Europe BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific BCG Vaccine Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific BCG Vaccine Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific BCG Vaccine Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America BCG Vaccine Sales Assessment of Players 2014-2020
11.4.2 South America BCG Vaccine Revenue Assessment of Players 2014-2020
11.4.3 South America BCG Vaccine Price Assessment of Players 2014-2020
11.4.4 South America BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa BCG Vaccine Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa BCG Vaccine Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa BCG Vaccine Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa BCG Vaccine Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific BCG Vaccine Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific BCG Vaccine Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific BCG Vaccine Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America BCG Vaccine Sales by Countries/Regions 2014-2020
12.2.2 North America BCG Vaccine Revenue by Countries/Regions 2014-2020
12.2.3 North America BCG Vaccine Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe BCG Vaccine Sales by Countries/Regions 2014-2020
12.3.2 Europe BCG Vaccine Revenue by Countries/Regions 2014-2020
12.3.3 Europe BCG Vaccine Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America BCG Vaccine Sales by Countries/Regions 2014-2020
12.4.2 South America BCG Vaccine Revenue by Countries/Regions 2014-2020
12.4.3 South America BCG Vaccine Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa BCG Vaccine Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa BCG Vaccine Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa BCG Vaccine Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World BCG Vaccine Sales & Revenue Forecast 2021-2026
14.1 World BCG Vaccine Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World BCG VaccineSales and Market Share by Regions
14.1.2 World BCG VaccineRevenue and Market Share by Regions
15 Asia BCG Vaccine Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Immune BCG
15.1.2 Therapy BCG
15.2 Consumption Forecast by Application, 2021-2026
16 North America BCG Vaccine Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Immune BCG
16.1.2 Therapy BCG
16.2 Consumption Forecast by Application, 2021-2026
17 Europe BCG Vaccine Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Immune BCG
17.1.2 Therapy BCG
17.2 Consumption Forecast by Application, 2021-2026
18 South America BCG Vaccine Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Immune BCG
18.1.2 Therapy BCG
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa BCG Vaccine Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Immune BCG
19.1.2 Therapy BCG
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global BCG Vaccine Price (USD/Unit) Trend 2021-2026
20.2 Global BCG Vaccine Gross Profit Trend 2021-2026
21 Conclusion
